Andersen O - Search Results

1

Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study.

Lindberg C, Andersen O, Lefvert AK. Lindberg C, et al. Among authors: andersen o. Acta Neurol Scand. 1998 Jun;97(6):370-3. doi: 10.1111/j.1600-0404.1998.tb05968.x. Acta Neurol Scand. 1998. PMID: 9669469 Clinical Trial.

2

Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathy.

Ernerudh JH, Vrethem M, Andersen O, Lindberg C, Berlin G. Ernerudh JH, et al. Among authors: andersen o. J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):930-4. doi: 10.1136/jnnp.55.10.930. J Neurol Neurosurg Psychiatry. 1992. PMID: 1279127 Free PMC article.

3

Remission rate after thymectomy in myasthenia gravis when the bias of immunosuppressive therapy is eliminated.

Lindberg C, Andersen O, Larsson S, Odén A. Lindberg C, et al. Among authors: andersen o. Acta Neurol Scand. 1992 Sep;86(3):323-8. doi: 10.1111/j.1600-0404.1992.tb05094.x. Acta Neurol Scand. 1992. PMID: 1414255

4

Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis.

Lindberg C, Andersen O, Vahlne A, Dalton M, Runmarker B. Lindberg C, et al. Among authors: andersen o. Neuroepidemiology. 1991;10(2):62-5. doi: 10.1159/000110248. Neuroepidemiology. 1991. PMID: 2062419

5

Centrolobular liver cell necrosis, myocardial infarction, and hyperamylasaemia after high dose corticosteroids.

Olsson R, Lindberg C, Andersen O. Olsson R, et al. Among authors: andersen o. BMJ. 1994 Feb 12;308(6926):454. doi: 10.1136/bmj.308.6926.454. BMJ. 1994. PMID: 8124178 Free PMC article. No abstract available.

6

Physical training effects in myasthenia gravis.

Lohi EL, Lindberg C, Andersen O. Lohi EL, et al. Among authors: andersen o. Arch Phys Med Rehabil. 1993 Nov;74(11):1178-80. Arch Phys Med Rehabil. 1993. PMID: 8239958

7

Multiple sclerosis siblings with cerebrospinal fluid immunopathy but without any indication of neuronal damage.

Haghighi S, Frisén L, Odén A, Andersen O. Haghighi S, et al. Among authors: andersen o. Acta Neurol Scand. 2003 Nov;108(5):319-22. doi: 10.1034/j.1600-0404.2003.00130.x. Acta Neurol Scand. 2003. PMID: 14616300

8

Cerebrospinal fluid markers in MS patients and their healthy siblings.

Haghighi S, Andersen O, Odén A, Rosengren L. Haghighi S, et al. Among authors: andersen o. Acta Neurol Scand. 2004 Feb;109(2):97-9. doi: 10.1034/j.1600-0404.2003.00197.x. Acta Neurol Scand. 2004. PMID: 14705970

9

Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.

Andersen O, Elovaara I, Färkkilä M, Hansen HJ, Mellgren SI, Myhr KM, Sandberg-Wollheim M, Soelberg Sørensen P. Andersen O, et al. J Neurol Neurosurg Psychiatry. 2004 May;75(5):706-10. doi: 10.1136/jnnp.2003.010090. J Neurol Neurosurg Psychiatry. 2004. PMID: 15090564 Free PMC article. Clinical Trial.

10

A SCA7 premutation may be a novel Mendelian modifier of MS course: A case report.

Sundal C, Axelsson M, Wiklund L, Lindberg C, Andersen O. Sundal C, et al. Among authors: andersen o. Mult Scler Relat Disord. 2019 Jun;31:148-150. doi: 10.1016/j.msard.2019.04.009. Epub 2019 Apr 13. Mult Scler Relat Disord. 2019. PMID: 30999137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,531 results

Search Page